Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Piper Sandler Maintains Neutral on Varonis Systems, Raises Price Target to $23

Piper Sandler analyst Rob Owens maintains Varonis Systems (NASDAQ:VRNS) with a Neutral and raises the price target from $20 to $23.

byBenzinga Newsdesk

January 5, 2023

1 minute read

Piper Sandler analyst Rob Owens maintains Varonis Systems (NASDAQ:VRNS) with a Neutral and raises the price target from $20 to $23.

FDA Gives ‘Most Severe’ Class I Label To Philips’ Recall Of Faulty Ventilators, Sleep Apnea Machines

By Vandana Singh

Today, 4:10 AM

The FDA handed down its Class I label, the most severe recall classification, for Koninkl

PHG

Teva Pharmaceutical Indus Q3 Adj. EPS $0.59 Misses $0.65 Estimate, Sales $3.89B Miss $4.03B Estimate; Reaffirms Guidance

By Benzinga Newsdesk

Today, 4:10 AM

Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.59 per share which missed the analyst consensus estimate of $0.65 by 9.23 percent. This is a 1.72 percent increase over earnings of $0.58 per share

TEVA

Wolfe Research Initiates Coverage On Americold Realty Trust with Peer Perform Rating, Announces Price Target of $37

By Benzinga Newsdesk

Today, 4:10 AM

Wolfe Research analyst Andrew Rosivach initiates coverage on Americold Realty Trust (NYSE:COLD) with a Peer Perform rating and announces Price Target of $37.

COLD